drugset / Trial / NCT01815307
Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare efficacy and safety of Gemcitabine versus S-1 adjuvant therapy after hemihepatectomy.
Timeline
- Start
- 2013-01
- Primary completion
- 2016-05
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 1000 mg/m2 | — |
| Subject | S-1 | Small molecule | 80 mg/m2 | — |